CalciMedica Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Cash & Equivalents	5.53	1.48	13.36	33.42	15.87	12.83
Short-Term Investments	5.71	0	50.31	61.62	20.09	0
Cash & Cash Equivalents	11.24	1.48	63.67	95.03	35.96	12.83
Cash Growth	661.38%	-97.68%	-33.00%	164.30%	180.16%	-
Other Current Assets	0.37	0.25	3.41	4.21	0.32	0.61
Total Current Assets	11.61	1.73	67.08	99.24	36.27	13.45
Property, Plant & Equipment	0.17	0.2	1.98	1.95	1.98	1.52
Other Long-Term Assets	0.41	1.42	0.03	0.61	2.41	2.85
Total Long-Term Assets	0.58	1.62	2.01	2.55	4.39	4.37
Total Assets	12.19	3.35	69.09	101.79	40.66	17.81
Accounts Payable	1.42	2.87	0.53	2.51	4.64	2.52
Other Current Liabilities	2.61	1.91	3.53	4.48	7.62	3.27
Total Current Liabilities	4.03	4.78	4.06	7	12.25	5.79
Long-Term Debt	0	5.16	0	0	0	0
Other Long-Term Liabilities	0	2.65	0.01	0.01	0	78.81
Total Long-Term Liabilities	0	7.8	0.01	0.01	0	78.81
Total Liabilities	4.03	12.58	4.07	7.01	12.25	84.61
Total Debt	0	5.16	0	0	0	0
Retained Earnings	-146.06	-111.71	-169.19	-133.37	-105.84	-68.8
Comprehensive Income	0	0	-0.02	-0	0	0
Shareholders' Equity	8.16	-71.3	65.02	94.79	-102.95	-66.79
Net Cash / Debt	11.24	-3.68	63.67	95.03	35.96	12.83
Net Cash / Debt Growth	-	-	-33.00%	164.30%	180.16%	-
Net Cash Per Share	2.50	-44.76	42.05	201.02	381.38	15.73
Working Capital	7.58	-3.05	63.02	92.24	24.02	7.65
Book Value Per Share	1.82	-866.97	42.94	200.50	-1092.01	-81.84

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).